№5(8) 2025

DOI 10.37219/2528-8253-2025-5-52

Shydlovska TA, Bezega MI, Shevtsova TV
PURE-TONE AND SPEECH AUDIOMETRY PARAMETERS IN INDIVIDUALS AFTER COVID-19 OF VARYING SEVERITY
Shydlovska Tetiana A.
State Institution “O.S. Kolomiychenko Institute of Otolaryngology of National Academy of Medical Science of Ukraine”; Kyiv, Ukraine.
Head of the laboratory of voice and hearing
Doctor of Medical Sciences, Professor
E-mail: lorprof3@ukr.net
Orchid ID: https://orcid.org/0000-0002-7894-359X
Bezega Mychailo I
Poltava State Medical University
Department of Otorhinolaryngology with Ophthalmology
Candidate of Medical Sciences
Email: lorbezega@gmail.com
ORCID ID: https://orcid.org/0000-0002-1250-1190
Shevtsova Tetiana V
State Institution “O.S. Kolomiychenko Institute of Otolaryngology of National Academy of Medical Science of Ukraine”; Kyiv, Ukraine.
Laboratory of Voice and Hearing
Researcher
E-mail: amtc@kndio.kiev.ua
Orchid ID: https://orcid.org/0009-0007-4331-2898

Abstract

Relevance: Coronavirus disease (COVID-19) may present with a wide range of manifestations and health consequences, including impairments of the sensory systems. Neurological and auditory manifestations can be observed both during the illness and after recovery.

The purpose of this study is to assess auditory function using subjective audiometry in patients who have recovered from COVID-19 of varying severity.

Materials and methods: A total of 54 patients with a history of COVID-19 and sensory system impairments were examined. The patients were divided into two groups according to the clinical course of the disease: the first group included 32 patients with a mild form of COVID-19, while the second group consisted of 22 patients who had experienced a moderate course of the disease.

The audiometric examination was performed in a soundproof booth, with a background noise level not exceeding 30 dB, using clinical audiometer AC 40 manufactured by Interacoustics (Denmark).

Results and discussion: According to subjective audiometry, patients who had recovered from COVID-19 and reported post-illness hearing impairment predominantly exhibited sensorineural hearing loss. In most cases of COVID-19 patients with sensorineural impairment, a gently sloping audiometric curve was observed, with the greatest elevation of hearing thresholds at high frequencies.

The mean hearing thresholds for pure tones in the conventional frequency range in patients from both groups were significantly elevated at 4; 6 and 8 kHz compared to the control group. Specifically, the 4 kHz threshold was 15,72±1,86 dB in Group 1 and 20,95±1,96 dB in Group 2. In Group 2, thresholds were also significantly higher than controls at 1; 2 and 3 kHz. At 6 and 8 kHz, a significant difference (P < 0,05) in hearing thresholds was observed between the two patient groups. Speech audiometry measures (50% numeral recognition test and 100% speech recognition test) in the examined patients were within normal limits.

The most pronounced elevation of pure-tone hearing thresholds was observed at 12; 14 and 16 kHz in the extended frequency range. In Group 1, thresholds were 67,9±2,14; 69,5±2,54 and 55,3±2,1 dB, respectively, while in Group 2 they were 70,9±2,18; 79,5±2,84 and 57,9±1,91 dB, respectively.

Conclusions:

In COVID-19, hearing impairments of the sensorineural type are observed, being more pronounced in cases with a more severe course of the disease.

The most pronounced and statistically significant elevation of hearing thresholds (P<0,01) relative to normal values was observed in the extended frequency range, as well as within the conventional range at 4, 6, and 8 kHz.

The elevation of hearing thresholds was more pronounced in the group of patients with a moderate course of COVID-19, with a statistically significant intergroup difference observed at 6 and 8 kHz.

Early detection of sensorineural hearing loss using subjective audiometry in the extended frequency range may facilitate timely initiation of treatment and implementation of preventive measures.

Keywords: subjective audiometry, sensorineural hearing loss, COVID-19.

References

  1. Rhman AS, Wahid AA. COVID-19 and sudden sensorineural hearing loss, a case report. Otolaryngol Case Rep. 2020 Sep;16:100198. doi: 10.1016/j.xocr.2020.100198.
  2. Bezega M. [Disorder of sound conduction function in patients with COVID-19]. Otorhynolaryngology. 2022;3-4(5):65-70. doi: 37219/2528-8253-2022-3-65. [Article in Ukrainian].
  3. Kilic O, Kalcioglu MT, Cag Y, Tuysuz O, Pektas E, Caskurlu H, Cetın F. Could sudden sensorineural hearing loss be the sole manifestation of COVID-19? An investigation into SARS-COV-2 in the etiology of sudden sensorineural hearing loss. Int J Infect Dis. 2020 Aug;97:208-211. doi: 10.1016/j.ijid.2020.06.023.
  4. Kitsera OO. [Changes in the hearing organ in COVID-19]. Proceedings of the XIII Congress of Otorhinolaryngologists of Ukraine; 2021; Odessa. Odessa, UA: 2021. P. 50. [In Ukrainian].
  5. Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers D, Kant KM, Kaptein FHJ, van Paassen J, Stals MAM, Huisman MV, Endeman H. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis. Thromb Res. 2020 Jul;191:148-150. doi: 10.1016/j.thromres.2020.04.041.
  6. Komisarenko S. [The global coronavirus crisis]. Kyiv: LAT&K; 2020. 120 p. [In Ukrainian].
  7. Krasnova AA. [Impact of COVID-19 on the course of chronic ischemic heart disease]. Ukr Med J. 2022;6:32-34. doi: 10.32471/umj.1680-3051.152.236628. [Article in Ukrainian].
  8. LaiCC, ShihTP, KoWC, TangHJ, HsuehPR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020 Mar;55(3):105924.doi: 10.1016/j.ijantimicag.2020.105924. 
  9. Levytska SA, Ponych OM, Palii MA, Andrushko SD. [ENT aspects of SARS-CoV-2: experience of Chernivtsi]. Proceedings of the XIII Congress of Otorhinolaryngologists of Ukraine; 2021; Odessa. Odessa, UA: 2021. P. 67-8. [In Ukrainian].
  10. Lisyany MI. [COVID-19 infection and autoimmune reactions]. Zh. 2022; 68(1): 87-92. doi: https://doi.org/10.15407/fz68.01.087. [Article in Ukrainian].
  11. Lisyany MI, Belskaya LM, Klyuchnikova AI, Krasilenko EP. [The state of long-term autoimmune and inflammatory reactions after COVID-19]. Fiziol. Zh. 2022; 68(5): 3-9. doi: https://doi.org/10.15407/fz68.05.003. [Article in Ukrainian].
  12. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020 Jun 1;77(6):683-690. doi: 10.1001/jamaneurol.2020.1127. 
  13. Mosiychuk [The phenomenon of mutual aggravation of COVID-19 and gastroesophageal reflux disease with laryngopharyngeal manifestations]. Ukr Med J. 2022; 4(150):56-60. doi: 10.32471/umj.1680-3051.150.232527 [Article in Ukrainian].
  14. Mustafa MWM. Audiological profile of asymptomatic COVID-19 PCR-positive cases. Am J Otolaryngol. 2020 May-Jun;41(3):102483. doi: 10.1016/j.amjoto.2020.102483.
  15. Shydlovska TA, Bezega MI. [Indicators of subjective audiometry in the conventional frequency range in patients with COVID-19]. Otorhynolaryngology. 2022;5 (5):23-28. doi: 10.37219/2528-8253-2022-5-23. [Article in Ukrainian].
  16. Shydlovska TA, Bezega MI, Medvedev VV, Shevtsova TV. Indicators of subjective audiometry in the extended frequency range in patients with COVID-19. Otorhynolaryngology. 2023;6(4):64-70.
  17. Trykhlib VI. [Complications in COVID-19 patients]. Infectious Diseases. 2022;(1):37-46. doi: https://doi.org/10.11603/1681-2727.2020.1.11097. [Article in Ukrainian].